{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:45:16Z","timestamp":1792788316276,"version":"4.5.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Institutes of Health","award":["T32AG087922"],"award-info":[{"award-number":["T32AG087922"]}]},{"name":"National Institutes of Health","award":["1R01NS137434"],"award-info":[{"award-number":["1R01NS137434"]}]},{"name":"National Institutes of Health","award":["R01NS105971"],"award-info":[{"award-number":["R01NS105971"]}]},{"name":"Alzheimer's Drug Discovery Foundation","id":[{"id":"https:\/\/ror.org\/0185drb55","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Association for Frontotemporal Degeneration, United States","id":[{"id":"https:\/\/ror.org\/03wkk5p21","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Bluefield Project to Cure Frontotemporal Dementia"},{"name":"BrightFocus Foundation","id":[{"id":"https:\/\/ror.org\/03cvfxv40","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS146190"],"award-info":[{"award-number":["R01NS146190"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol. Neurodegener. Adv."],"DOI":"10.1186\/s44477-026-00055-8","type":"journal-article","created":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T13:59:04Z","timestamp":1791295144000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Monospecific antibodies reveal reduction of granulins in frontotemporal dementia caused by GRN mutations"],"prefix":"10.1186","volume":"2","author":[{"given":"Paola","family":"Merino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludmilla Troiano","family":"Araujo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anarmaa","family":"Mendsaikhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgia","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chloe","family":"Heath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingee","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary T.","family":"McEachin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3750-6262","authenticated-orcid":false,"given":"Thomas","family":"Kukar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,6]]},"reference":[{"issue":"7105","key":"55_CR1","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1038\/nature05016","volume":"442","author":"M Baker","year":"2006","unstructured":"Baker M, et al. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature. 2006;442(7105):916\u20139.","journal-title":"Nature"},{"issue":"7105","key":"55_CR2","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1038\/nature05017","volume":"442","author":"M Cruts","year":"2006","unstructured":"Cruts M, et al. Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21. Nature. 2006;442(7105):920\u20134.","journal-title":"Nature"},{"issue":"20","key":"55_CR3","doi-asserted-by":"publisher","first-page":"2988","DOI":"10.1093\/hmg\/ddl241","volume":"15","author":"J Gass","year":"2006","unstructured":"Gass J, et al. Mutations in progranulin are a major cause of ubiquitin-positive frontotemporal lobar degeneration. Hum Mol Genet. 2006;15(20):2988\u20133001.","journal-title":"Hum Mol Genet"},{"issue":"Pt 3","key":"55_CR4","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1093\/brain\/awn352","volume":"132","author":"N Finch","year":"2009","unstructured":"Finch N, et al. Plasma progranulin levels predict progranulin mutation status in frontotemporal dementia patients and asymptomatic family members. Brain. 2009;132(Pt 3):583\u201391.","journal-title":"Brain"},{"issue":"2","key":"55_CR5","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1159\/000447738","volume":"6","author":"LH Meeter","year":"2016","unstructured":"Meeter LH, et al. Progranulin levels in plasma and cerebrospinal fluid in granulin mutation carriers. Dement Geriatr Cogn Dis Extra. 2016;6(2):330\u201340.","journal-title":"Dement Geriatr Cogn Dis Extra"},{"issue":"6","key":"55_CR6","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1016\/j.ajhg.2012.04.021","volume":"90","author":"KR Smith","year":"2012","unstructured":"Smith KR, et al. Strikingly different clinicopathological phenotypes determined by progranulin-mutation dosage. Am J Hum Genet. 2012;90(6):1102\u20137.","journal-title":"Am J Hum Genet"},{"issue":"1","key":"55_CR7","doi-asserted-by":"publisher","first-page":"311","DOI":"10.2353\/ajpath.2010.090915","volume":"177","author":"Z Ahmed","year":"2010","unstructured":"Ahmed Z, et al. Accelerated lipofuscinosis and ubiquitination in granulin knockout mice suggest a role for progranulin in successful aging. Am J Pathol. 2010;177(1):311\u201324.","journal-title":"Am J Pathol"},{"issue":"6","key":"55_CR8","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1001\/2013.jamaneurol.393","volume":"70","author":"DC Perry","year":"2013","unstructured":"Perry DC, et al. Progranulin mutations as risk factors for Alzheimer disease. JAMA Neurol. 2013;70(6):774\u20138.","journal-title":"JAMA Neurol"},{"issue":"8","key":"55_CR9","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.tips.2021.11.015","volume":"43","author":"H Rhinn","year":"2022","unstructured":"Rhinn H, et al. Progranulin as a therapeutic target in neurodegenerative diseases. Trends Pharmacol Sci. 2022;43(8):641\u201352.","journal-title":"Trends Pharmacol Sci"},{"issue":"4","key":"55_CR10","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1007\/s00415-014-7630-2","volume":"262","author":"Y Chen","year":"2015","unstructured":"Chen Y, et al. Association of progranulin polymorphism rs5848 with neurodegenerative diseases: a meta-analysis. J Neurol. 2015;262(4):814\u201322.","journal-title":"J Neurol"},{"key":"55_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2020.134873","volume":"725","author":"YN Yao","year":"2020","unstructured":"Yao YN, et al. Reduced plasma progranulin levels are associated with the severity of Parkinson\u2019s disease. Neurosci Lett. 2020;725:134873.","journal-title":"Neurosci Lett"},{"issue":"1","key":"55_CR12","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/s40478-021-01250-2","volume":"9","author":"AJ Dugan","year":"2021","unstructured":"Dugan AJ, et al. Analysis of genes (TMEM106B, GRN, ABCC9, KCNMB2, and APOE) implicated in risk for LATE-NC and hippocampal sclerosis provides pathogenetic insights: a retrospective genetic association study. Acta Neuropathol Commun. 2021;9(1):152.","journal-title":"Acta Neuropathol Commun"},{"issue":"6","key":"55_CR13","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/S0092-8674(02)01141-8","volume":"111","author":"J Zhu","year":"2002","unstructured":"Zhu J, et al. Conversion of proepithelin to epithelins: roles of SLPI and elastase in host defense and wound repair. Cell. 2002;111(6):867\u201378.","journal-title":"Cell"},{"issue":"7","key":"55_CR14","first-page":"2438","volume":"118","author":"K Kessenbrock","year":"2008","unstructured":"Kessenbrock K, Fr\u00f6hlich L, Sixt M, L\u00e4mmermann T, Pfister H, Bateman A, et al. Proteinase 3 and neutrophil elastase enhance inflammation in mice by inactivating antiinflammatory progranulin. J Clin Invest. 2008;118(7):2438\u201347.","journal-title":"J Clin Invest"},{"key":"55_CR15","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/978-3-030-51140-1_14","volume":"1281","author":"X Zhou","year":"2021","unstructured":"Zhou X, Kukar T, Rademakers R. Lysosomal dysfunction and other pathomechanisms in FTLD: evidence from progranulin genetics and biology. Adv Exp Med Biol. 2021;1281:219\u201342.","journal-title":"Adv Exp Med Biol"},{"key":"55_CR16","doi-asserted-by":"publisher","DOI":"10.1523\/ENEURO.0100-17.2017","author":"CJ Holler","year":"2017","unstructured":"Holler CJ, et al. Intracellular proteolysis of progranulin generates stable, lysosomal granulins that are haploinsufficient in patients with frontotemporal dementia caused by GRN mutations. eNeuro. 2017. https:\/\/doi.org\/10.1523\/ENEURO.0100-17.2017.","journal-title":"eNeuro"},{"issue":"1","key":"55_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-017-0196-6","volume":"12","author":"CW Lee","year":"2017","unstructured":"Lee CW, et al. The lysosomal protein cathepsin L is a progranulin protease. Mol Neurodegener. 2017;12(1):55.","journal-title":"Mol Neurodegener"},{"issue":"1","key":"55_CR18","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s13024-017-0205-9","volume":"12","author":"X Zhou","year":"2017","unstructured":"Zhou X, et al. Lysosomal processing of progranulin. Mol Neurodegener. 2017;12(1):62.","journal-title":"Mol Neurodegener"},{"issue":"25","key":"55_CR19","doi-asserted-by":"publisher","first-page":"9315","DOI":"10.1523\/JNEUROSCI.4808-14.2015","volume":"35","author":"DA Salazar","year":"2015","unstructured":"Salazar DA, et al. The progranulin cleavage products, granulins, exacerbate TDP-43 toxicity and increase TDP-43 levels. J Neurosci. 2015;35(25):9315\u201328.","journal-title":"J Neurosci"},{"issue":"8","key":"55_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1008295","volume":"15","author":"VJ Butler","year":"2019","unstructured":"Butler VJ, et al. Age- and stress-associated C. elegans granulins impair lysosomal function and induce a compensatory HLH-30\/TFEB transcriptional response. PLoS Genet. 2019;15(8):e1008295.","journal-title":"PLoS Genet"},{"issue":"12","key":"55_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.114985","volume":"43","author":"J Root","year":"2024","unstructured":"Root J, et al. Granulins rescue inflammation, lysosome dysfunction, lipofuscin, and neuropathology in a mouse model of progranulin deficiency. Cell Rep. 2024;43(12):114985.","journal-title":"Cell Rep"},{"issue":"11","key":"55_CR22","doi-asserted-by":"publisher","first-page":"3223","DOI":"10.1021\/bm800801b","volume":"9","author":"H Wang","year":"2008","unstructured":"Wang H, et al. Single-site Cys-substituting mutation of human lectin galectin-2: modulating solubility in recombinant production, reducing long-term aggregation, and enabling site-specific monoPEGylation. Biomacromolecules. 2008;9(11):3223\u201330.","journal-title":"Biomacromolecules"},{"issue":"3","key":"55_CR23","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1080\/21645515.2016.1242540","volume":"13","author":"CA Seid","year":"2017","unstructured":"Seid CA, et al. Cysteine mutagenesis improves the production without abrogating antigenicity of a recombinant protein vaccine candidate for human chagas disease. Hum Vaccin Immunother. 2017;13(3):621\u201333.","journal-title":"Hum Vaccin Immunother"},{"issue":"2","key":"55_CR24","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S0168-1656(00)00258-3","volume":"80","author":"M Larsson","year":"2000","unstructured":"Larsson M, et al. High-throughput protein expression of cDNA products as a tool in functional genomics. J Biotechnol. 2000;80(2):143\u201357.","journal-title":"J Biotechnol"},{"issue":"2","key":"55_CR25","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1042\/BA20010097","volume":"35","author":"S Gr\u00e4slund","year":"2002","unstructured":"Gr\u00e4slund S, et al. A high-stringency proteomics concept aimed for generation of antibodies specific for cDNA-encoded proteins. Biotechnol Appl Biochem. 2002;35(2):75\u201382.","journal-title":"Biotechnol Appl Biochem"},{"issue":"2","key":"55_CR26","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1006\/prep.2001.1520","volume":"23","author":"R Levy","year":"2001","unstructured":"Levy R, et al. Production of correctly folded Fab antibody fragment in the cytoplasm of Escherichia coli trxB gor mutants via the coexpression of molecular chaperones. Protein Expr Purif. 2001;23(2):338\u201347.","journal-title":"Protein Expr Purif"},{"issue":"9","key":"55_CR27","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1002\/pro.3212","volume":"26","author":"G Ghag","year":"2017","unstructured":"Ghag G, et al. Disulfide bonds and disorder in granulin-3: an unusual handshake between structural stability and plasticity. Protein Sci. 2017;26(9):1759\u201372.","journal-title":"Protein Sci"},{"issue":"12","key":"55_CR28","doi-asserted-by":"publisher","first-page":"8627","DOI":"10.1074\/jbc.M112.441949","volume":"288","author":"AD Nguyen","year":"2013","unstructured":"Nguyen AD, et al. Secreted progranulin is a homodimer and is not a component of high density lipoproteins (HDL). J Biol Chem. 2013;288(12):8627\u201335.","journal-title":"J Biol Chem"},{"issue":"15","key":"55_CR29","doi-asserted-by":"publisher","first-page":"10863","DOI":"10.1016\/S0021-9258(18)82064-6","volume":"268","author":"J Zhou","year":"1993","unstructured":"Zhou J, et al. Purification of an autocrine growth factor homologous with mouse epithelin precursor from a highly tumorigenic cell line. J Biol Chem. 1993;268(15):10863\u20139.","journal-title":"J Biol Chem"},{"issue":"8","key":"55_CR30","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1016\/j.jprot.2010.02.013","volume":"73","author":"K Songsrirote","year":"2010","unstructured":"Songsrirote K, et al. Development and application of mass spectrometric methods for the analysis of progranulin N-glycosylation. J Proteomics. 2010;73(8):1479\u201390.","journal-title":"J Proteomics"},{"key":"55_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2024.151150","volume":"742","author":"Y Liang","year":"2025","unstructured":"Liang Y, et al. O-GlcNAcylation of progranulin promotes hepatocellular carcinoma proliferation. Biochem Biophys Res Commun. 2025;742:151150.","journal-title":"Biochem Biophys Res Commun"},{"issue":"7","key":"55_CR32","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1177\/002215540004800713","volume":"48","author":"R Daniel","year":"2000","unstructured":"Daniel R, et al. Cellular localization of gene expression for progranulin. J Histochem Cytochem. 2000;48(7):999\u20131009.","journal-title":"J Histochem Cytochem"},{"issue":"4","key":"55_CR33","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1002\/dvdy.10341","volume":"227","author":"R Daniel","year":"2003","unstructured":"Daniel R, et al. Progranulin (acrogranin\/PC cell-derived growth factor\/granulin-epithelin precursor) is expressed in the placenta, epidermis, microvasculature, and brain during murine development. Dev Dyn. 2003;227(4):593\u20139.","journal-title":"Dev Dyn"},{"issue":"1","key":"55_CR34","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13024-021-00472-1","volume":"16","author":"S Mohan","year":"2021","unstructured":"Mohan S, et al. Processing of progranulin into granulins involves multiple lysosomal proteases and is affected in frontotemporal lobar degeneration. Mol Neurodegener. 2021;16(1):51.","journal-title":"Mol Neurodegener"},{"key":"55_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2021.105360","volume":"154","author":"J Root","year":"2021","unstructured":"Root J, et al. Lysosome dysfunction as a cause of neurodegenerative diseases: lessons from frontotemporal dementia and amyotrophic lateral sclerosis. Neurobiol Dis. 2021;154:105360.","journal-title":"Neurobiol Dis"},{"issue":"1","key":"55_CR36","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s40478-020-01037-x","volume":"8","author":"M Huang","year":"2020","unstructured":"Huang M, et al. Network analysis of the progranulin-deficient mouse brain proteome reveals pathogenic mechanisms shared in human frontotemporal dementia caused by GRN mutations. Acta Neuropathol Commun. 2020;8(1):163.","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"55_CR37","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13024-021-00513-9","volume":"17","author":"T Zhang","year":"2022","unstructured":"Zhang T, et al. Differential regulation of progranulin derived granulin peptides. Mol Neurodegener. 2022;17(1):15.","journal-title":"Mol Neurodegener"},{"key":"55_CR38","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jaut.2015.05.002","volume":"61","author":"L Thurner","year":"2015","unstructured":"Thurner L, et al. The molecular basis for development of proinflammatory autoantibodies to progranulin. J Autoimmun. 2015;61:17\u201328.","journal-title":"J Autoimmun"},{"issue":"9","key":"55_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2022.102348","volume":"298","author":"MN Santos","year":"2022","unstructured":"Santos MN, et al. Progranulin-derived granulin E and lysosome membrane protein CD68 interact to reciprocally regulate their protein homeostasis. J Biol Chem. 2022;298(9):102348.","journal-title":"J Biol Chem"},{"key":"55_CR40","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics12061490","author":"MA Sacco","year":"2022","unstructured":"Sacco MA, et al. Systematic review on post-mortem protein alterations: analysis of experimental models and evaluation of potential biomarkers of time of death. Diagnostics (Basel). 2022. https:\/\/doi.org\/10.3390\/diagnostics12061490.","journal-title":"Diagnostics (Basel)"},{"issue":"2","key":"55_CR41","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.2881","volume":"13","author":"MC McKenna","year":"2023","unstructured":"McKenna MC, et al. Thalamic pathology in frontotemporal dementia: predilection for specific nuclei, phenotype-specific signatures, clinical correlates, and practical relevance. Brain Behav. 2023;13(2):e2881.","journal-title":"Brain Behav"},{"issue":"8","key":"55_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109581","volume":"36","author":"Y Wu","year":"2021","unstructured":"Wu Y, et al. Microglial lysosome dysfunction contributes to white matter pathology and TDP-43 proteinopathy in GRN-associated FTD. Cell Rep. 2021;36(8):109581.","journal-title":"Cell Rep"},{"key":"55_CR43","doi-asserted-by":"publisher","DOI":"10.1172\/JCI164919","author":"E Marsan","year":"2023","unstructured":"Marsan E, et al. Astroglial toxicity promotes synaptic degeneration in the thalamocortical circuit in frontotemporal dementia with GRN mutations. J Clin Invest. 2023. https:\/\/doi.org\/10.1172\/JCI164919.","journal-title":"J Clin Invest"},{"issue":"3","key":"55_CR44","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1093\/hmg\/ddad184","volume":"33","author":"AL Wang","year":"2024","unstructured":"Wang AL, Mambou EA, Kao AW. The progranulin cleavage product granulin 3 exerts a dominant negative effect on animal fitness. Hum Mol Genet. 2024;33(3):245\u201353.","journal-title":"Hum Mol Genet"},{"issue":"12","key":"55_CR45","doi-asserted-by":"publisher","first-page":"E2849","DOI":"10.1073\/pnas.1722344115","volume":"115","author":"AD Nguyen","year":"2018","unstructured":"Nguyen AD, et al. Murine knockin model for progranulin-deficient frontotemporal dementia with nonsense-mediated mRNA decay. Proc Natl Acad Sci U S A. 2018;115(12):E2849-58.","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Molecular Neurodegeneration Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s44477-026-00055-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s44477-026-00055-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s44477-026-00055-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T13:59:06Z","timestamp":1791295146000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s44477-026-00055-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,6]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["55"],"URL":"https:\/\/doi.org\/10.1186\/s44477-026-00055-8","relation":{},"ISSN":["3059-4944"],"issn-type":[{"value":"3059-4944","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,6]]},"assertion":[{"value":"13 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All applicable international, national, and\/or institutional guidelines for the care and use of animals were followed. Human Ethics and Consent to Participate declarations: not applicable.IRB approval was not necessary because all samples were\u00a0from deceased individuals. Human post-mortem tissue was obtained from the Emory University Brain Bank, Mayo Clinic Brain Bank, and Banner Sun Health Research Institute Brain and Body Donation Program with Research Ethics Committee approval.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"47"}}